Cryofocus Medtech (Shanghai) Co., Ltd. (HKG:6922)

HKG:6922 Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Assets

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	59.27	35.03	45.46	103.4	226.42	157.87
Short-Term Investments	-	0.67	0.81	1.05	1.92	1.43
Cash & Short-Term Investments	59.27	35.71	46.26	104.46	228.34	159.3
Cash Growth	-6.92%	-22.82%	-55.71%	-54.25%	43.34%	379.37%
Receivables	-	0.04	0.06	0.13	0.08	0.25
Inventory	36.57	32.88	29.87	24.35	19.93	11.7
Restricted Cash	-	-	0	0.07	-	-
Other Current Assets	24.6	22.6	21.97	20.9	15.86	18.15
Total Current Assets	120.44	91.23	98.16	149.92	264.21	189.39
Property, Plant & Equipment	28.57	31.34	38.62	51.28	41.76	38.09
Other Intangible Assets	15.19	-	0	0.02	0.04	0.06
Other Long-Term Assets	-	14.89	12.47	11.61	7.85	4.15
Total Assets	164.2	137.46	149.25	212.82	313.86	231.69

Liabilities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Accounts Payable	1.29	3.66	2.41	1.15	1.87	0.38
Accrued Expenses	-	13.16	17.05	21.68	34.77	21.07
Short-Term Debt	29.48	13.13	30	-	-	-
Current Portion of Leases	7.19	9.35	5.6	3.25	3.43	2.6
Current Income Taxes Payable	-	3.53	1.69	2.07	1.98	1.41
Current Unearned Revenue	0.69	0.39	1.17	0.99	3.26	2.64
Other Current Liabilities	34.18	17.03	1.9	1.64	0.42	0.2
Total Current Liabilities	72.83	60.24	59.82	30.78	45.73	28.29
Long-Term Leases	3.86	3.72	7.72	7.76	7.94	6.41
Long-Term Unearned Revenue	8.1	8.06	2.78	0.82	0.8	-
Other Long-Term Liabilities	16.63	16.91	-	-	-	-
Total Liabilities	101.41	88.92	70.32	39.36	54.47	34.7

Shareholders' Equity

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Common Stock	244.71	239.11	239.11	239.11	239.11	228
Additional Paid-In Capital	-	299.77	299.77	299.77	299.77	150.64
Retained Earnings	-	-773.5	-735.33	-630.96	-533.48	-421.25
Comprehensive Income & Other	-178.89	284.36	270.3	253.55	233.73	213.26
Total Common Equity	65.82	49.74	73.85	161.47	239.13	170.65
Minority Interest	-3.03	-1.2	5.08	12	20.26	26.35
Shareholders' Equity	62.79	48.53	78.93	173.46	259.39	197
Total Liabilities & Equity	164.2	137.46	149.25	212.82	313.86	231.69

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Total Debt	40.53	26.2	43.32	11.01	11.37	9
Net Cash (Debt)	18.75	9.51	2.94	93.44	216.97	150.3
Net Cash Growth	-26.60%	223.44%	-96.86%	-56.93%	44.36%	360.28%
Net Cash Per Share	0.08	0.04	0.01	0.39	0.95	0.66
Filing Date Shares Outstanding	244.71	239.11	239.11	239.11	239.11	228
Total Common Shares Outstanding	244.71	239.11	239.11	239.11	239.11	228
Working Capital	47.61	30.99	38.34	119.13	218.47	161.1
Book Value Per Share	0.27	0.21	0.31	0.68	1.00	0.75
Tangible Book Value	50.63	49.74	73.85	161.44	239.09	170.59
Tangible Book Value Per Share	0.21	0.21	0.31	0.68	1.00	0.75
Buildings	-	19.24	19.24	19.24	-	-
Machinery	-	23.14	22.84	18.42	34.29	29.54
Construction In Progress	-	0.31	0.49	10.15	0.8	3.27
Leasehold Improvements	-	24.22	23.75	15.58	13.8	9.56

Data Source: S&P Global Market Intelligence Last updated: Aug 28, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every six months for this company.

Update frequency:

Semi-annually

Last checked:

Sep 13, 2026

Data Sources Report a data error